.png)
About SHINE:
Headquartered in Janesville, Wisconsin, SHINE Technologies is an industry leader in next-generation fusion, deploying innovative fusion and fusion-based technology that seamlessly combines safety, cost-efficiency, and environmental responsibility. SHINE's fusion expertise drives innovation across multiple sectors, from advanced radiation testing for aerospace and defense to medical isotope production for cancer treatments.
The company's groundbreaking fusion systems support critical applications in national security, scientific research, and industrial testing. Simultaneously, SHINE is pioneering solutions in healthcare, producing essential medical isotopes like lutetium-177 and soon, molybdenum-99 for diagnostic and therapeutic use.
Looking to the future, SHINE is leveraging its fusion knowledge to tackle complex energy challenges, including the potential for nuclear waste recycling and clean energy generation. With this comprehensive approach, SHINE continues to push the boundaries of fusion technology, driving advancements that promise to create a safer, healthier, and more sustainable world.
About the Oncidiumfoundation:
The Oncidium foundation is a nonprofit organization dedicated to advancing global access to radiotheranostics for cancer care, founded in 2011 by Dr. Richard Zimmermann. The foundation's priorities include raising awareness about radiotheranostics among patients and physicians, investing in research and scholarships, supporting and financing the development of new radiopharmaceuticals for therapy, supporting clinical best practices, and improving access to patients globally.
For more information visit www.oncidiumfoundation.org or the RLT-Connect platform: rltconnect.oncidiumfoundation.org and follow Oncidium on LinkedIn and X.
